Recent News for TRDA - Entrada Therapeutics, Inc.

Date	Title
Mar 13	Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 21	Entrada Therapeutics CEO discloses sale of 1K shares
Jan 29	‘Time to Pull the Trigger,’ Says Oppenheimer About These 3 Stocks
Jan 8	Amicus (FOLD) Issues Preliminary Revenue Results for FY23